{"title":"Clinical Trials of COVID-19 in China","authors":"Michele Brian","doi":"10.35248/0975-0851.21.S2.E001","DOIUrl":null,"url":null,"abstract":"This article hopes to summarize the fundamental attributes of enlisted preliminaries of 2019 novel (COVID-19), to the extent their spatial and transitory scatterings, kinds of plan and mediations, and patient characteristics among others. A sweeping inquiry of the enlisted COVID-19 preliminaries has been performed on stages including ClinicalTrials.gov, WHO International Clinical Trials Registry Platform (WHO ICTRP), Chinese Clinical Trials Registry (CHiCTR), Australian Clinical Trials Registry, Britain's National Research Register (BNRR), Current Control Trials (CCT), and Glaxo Smith Kline Register. Starters enrolled at the underlying two months of the COVID-19 erupt are consolidated, without language restrictions. For every assessment, the enlistment information, study plan, and chief information are assembled and summarized.","PeriodicalId":15184,"journal":{"name":"Journal of Bioequivalence & Bioavailability","volume":"47 1","pages":"1-1"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bioequivalence & Bioavailability","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/0975-0851.21.S2.E001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
This article hopes to summarize the fundamental attributes of enlisted preliminaries of 2019 novel (COVID-19), to the extent their spatial and transitory scatterings, kinds of plan and mediations, and patient characteristics among others. A sweeping inquiry of the enlisted COVID-19 preliminaries has been performed on stages including ClinicalTrials.gov, WHO International Clinical Trials Registry Platform (WHO ICTRP), Chinese Clinical Trials Registry (CHiCTR), Australian Clinical Trials Registry, Britain's National Research Register (BNRR), Current Control Trials (CCT), and Glaxo Smith Kline Register. Starters enrolled at the underlying two months of the COVID-19 erupt are consolidated, without language restrictions. For every assessment, the enlistment information, study plan, and chief information are assembled and summarized.